Find out what AI has already brought to Alzheimer's disease research and most importantly, what it can accomplish in the ...

In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused ...

What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress.

Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.

The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How ...

Delve into the field of severe epilepsies as new treatments for Dravet syndrome are progressing through the pipeline.

Discover how next-generation "switchable" CAR-T cells could improve both the safety and efficacy of CAR-T therapies.

Discover top biotech associations that drive industry growth through collaboration, networking, and strategic partnerships ...

Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the ...

As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related ...

RNA editing has picked up steam in recent years as a potentially safer alternative to gene editing to treat genetic diseases.